SID 2026Abstract 1047Laboratory research
Preclinical characterization of BCX17725, a potent inhibitor of KLK5/14, for the treatment of Netherton Syndrome
Ma Y, Cheng X, Liu Q, Nestor S, Parker C, Wang J, Wu M, Zhu F, Babu Y, Chen X
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Genetic skin disease
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1078 · Not in PubMed: details from Crossref